The NAD+ 1000mg & Retatrutide: The UK Innovation in Physiological Wellbeing
Emerging data from the UK are generating considerable excitement surrounding the potential combination of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unique approach aims to address multiple facets of metabolic dysfunction , potentially offering